Yaroslav Shuraev
According to a recent AP article, Indian manufacturer Kilitch Healthcare India, responsible for the recalled eyedrops sold in the U.S., faces significant sanitation and manufacturing issues, including barefoot workers, cracked floors, and altered records. A preliminary inspection report by the U.S. FDA revealed numerous problems at the Mumbai plant, which produced over two dozen eyedrop varieties subject to an FDA safety warning.
